Yin, Donghua

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma

Noel, M., O’Reilly, E. M., Wolpin, B. M., Ryan, D. P., Bullock, A. J., Britten, C. D., Linehan, D. C., Belt, B. A., Gamelin, E. C., Ganguly, B., et al. (2020) · Investigational New Drugs

Pancreatic and Hepatic Oncology ResearchChemokine receptors and signaling

Cited by 199

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., Paccagnella, M. L., de Bono, J. S., Gualberto, A., & Hammer, G. D. (2010) · Cancer Chemotherapy and Pharmacology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 197

Clinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder Cancer

Dalton, J. T., Yates, C. R., Yin, D., Straughn, A., Marcus, S. L., Golub, A. L., & Meyer, M. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 75

Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs

Gao, W., Liu, J., Musante, C. J., Zhu, H., Thompson, M., Shah, M., Cao, Y., Ivaturi, V., Conaway, M. R., Bottino, D., et al. (2025) · Clinical Pharmacology & Therapeutics

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 2